ID28387A - Metoda baru untuk vaksinasi terapeutik - Google Patents

Metoda baru untuk vaksinasi terapeutik

Info

Publication number
ID28387A
ID28387A IDW00200100963A ID20010963A ID28387A ID 28387 A ID28387 A ID 28387A ID W00200100963 A IDW00200100963 A ID W00200100963A ID 20010963 A ID20010963 A ID 20010963A ID 28387 A ID28387 A ID 28387A
Authority
ID
Indonesia
Prior art keywords
new method
therapeutic vaccination
vaccination
therapeutic
new
Prior art date
Application number
IDW00200100963A
Other languages
English (en)
Indonesian (id)
Inventor
Lucilla Steinaa
Soren Mouritsen
Anand Gautam
Iben Dalum
Jesper Haaning
Dana Leach
Klaus Gregorius Nielsen
Gunilla Karlsson
Peter Birk Rasmussen
Original Assignee
M & E Biotech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M & E Biotech As filed Critical M & E Biotech As
Publication of ID28387A publication Critical patent/ID28387A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4202—Receptors, cell surface antigens or cell surface determinants
    • A61K40/4203—Receptors for growth factors
    • A61K40/4205—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ ErbB4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4225—Growth factors
    • A61K40/4227—Fibroblast growth factors [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4274—Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; Prostatic acid phosphatase [PAP]; Prostate-specific G-protein-coupled receptor [PSGR]
    • A61K40/4276—Prostate specific membrane antigen [PSMA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/58—Prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDW00200100963A 1998-10-05 1999-10-05 Metoda baru untuk vaksinasi terapeutik ID28387A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801261 1998-10-05
US10500198P 1998-10-20 1998-10-20

Publications (1)

Publication Number Publication Date
ID28387A true ID28387A (id) 2001-05-17

Family

ID=27675502

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200100963A ID28387A (id) 1998-10-05 1999-10-05 Metoda baru untuk vaksinasi terapeutik

Country Status (5)

Country Link
EP (1) EP1502602A3 (de)
DK (1) DK1117421T3 (de)
ID (1) ID28387A (de)
SI (1) SI1117421T1 (de)
ZA (1) ZA200102603B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008040759A1 (en) * 2006-10-03 2008-04-10 Pharmexa A/S Method for down-regulation of cripto
CN103091499B (zh) * 2013-01-23 2015-07-08 三峡大学 一种肿瘤标志物钙网蛋白检测试剂盒的制备及应用
CN112010960A (zh) * 2020-09-10 2020-12-01 热休(厦门)细胞生物科技有限公司 一种肿瘤抗原复合物体外致敏dc、t细胞获得肿瘤特异性杀伤细胞ctl及其制备方法
CN116747298B (zh) * 2023-08-09 2024-01-02 成都新诺明生物科技有限公司 一种水痘-带状疱疹病毒疫苗及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
EP0735893B1 (de) * 1993-09-14 2008-11-26 Pharmexa Inc. Pan dr-bindeproteinen zur erhöhung der immunantwort
AUPO390396A0 (en) * 1996-11-29 1996-12-19 Csl Limited Novel promiscuous T helper cell epitopes
GB9711957D0 (en) * 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
GB9717953D0 (en) * 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
CA2319309C (en) * 1998-02-05 2010-08-10 Smithkline Beecham Biologicals S.A. Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination

Also Published As

Publication number Publication date
EP1502602A2 (de) 2005-02-02
EP1502602A3 (de) 2006-05-17
DK1117421T3 (da) 2004-11-01
SI1117421T1 (en) 2004-12-31
ZA200102603B (en) 2002-09-30

Similar Documents

Publication Publication Date Title
ID30339A (id) Metode pengobatan baru
HUP0103976A3 (en) Novel methods for therapeutic vaccination
DE69805250D1 (de) Ausführungsverfahren zum sanften Weiterreichen
PT1105382E (pt) Metodo para a preparacao de citalopran
NO20006319L (no) Terapeutiske biarylderivater
NO20010953L (no) En fremgangsmåte for behandling av stafylokokkal sykdom
ID21999A (id) Proses baru
ID27483A (id) Metoda terapi gen
ID24383A (id) Proses baru
ID16247A (id) Metode baru
FI970564L (fi) Uusi menetelmä di-isopinokamfeyyliklooriboraanin valmistamiseksi
ID28387A (id) Metoda baru untuk vaksinasi terapeutik
ID20093A (id) Metode untuk memproduksi polibutilena tereptalat
NO306097B1 (no) Fremgangsmåte for fremstilling av en kölle
ID22651A (id) Proses baru
FI972694L (fi) Uusi menetelmä sameridiinin valmistamiseksi
FI972389A7 (fi) Uusi menetelmä ranitidiinin valmistamiseksi
FI991617L (fi) Menetelmä vasteen tuottamiseksi
ID29042A (id) Metode pengobatan baru
FI981251A0 (fi) Menetelmä iso-tiosynnaattien valmistamiseksi
IT1299199B1 (it) Procedimento per preparare un collirio a base di diclofenac
GB9719189D0 (en) New therapeutic method
GB9719176D0 (en) New therapeutic method
FI981950A0 (fi) Menetelmä pellon metsittämiseen
ID18105A (id) Piperidin baru